ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,135, issued on Sept. 2, was assigned to Bayer AG (Leverkusen, Germany), The Broad Institute Inc. (Cambridge, Mass.) and Dana-Farber Cancer Institute Inc. (Boston).
"4H-pyrrolo[3,2-cpyridin-4-one derivatives" was invented by Franziska Siegel (Cambridge, Mass.), Daniel Korr (Berlin), Jens Schroder (Berlin), Stephan Siegel (Berlin), Heidi Greulich (Cambridge, Mass.), Bethany Kaplan (Cambridge, Mass.) and Matthew Meyerson (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of formula (I) for use in the treatment or prophylaxis of a disease, which is a hyperproliferative disease and/or a disorder responsive to induction of cell death, select...